Molecular predictors for anaemia after kidney transplantation

Nephrology Dialysis Transplantation

Volumn 24, Issue 3, 2009, Pages 1015-1023

  Wilflingseder, Julia ^a,b   Kainz, Alexander ^a,b   Perco, Paul ^b,c   Korbély, Reka ^a   Mayer, Bernd ^c   Oberbauer, Rainer ^a,b,d  

^a KH Elisabethinen ^*  (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Emergentec Biodevelopment GmbH   (Austria)

^d Austrian Dialysis and Transplant Registry   (Austria)

Author keywords

Biomarker; Erythropoetin; Gene expression; Inflammation; Renal transplantation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUTATHIONE TRANSFERASE T1;

ADULT; AGED; ALGORITHM; ANEMIA; ARTICLE; BCAR GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; ENGRAFTMENT; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION; GENOME; HUMAN; IMMUNE RESPONSE; INFLAMMATION; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SPRR2C GENE;

EID: 60749094249     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn683     Document Type: Article

References (47)

1. Shah N, Al-Khoury S, Afzali B et al. Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors. Transplantation 2006; 81: 1112-1118
2. Karthikeyan V, Karpinski J, Nair RC et al. The burden of chronic kidney disease in renal transplant recipients. Am J Transplant 2004; 4: 262-269
3. Kausman JY, Powell HR, Jones CL. Anemia in pediatric renal transplant recipients. Pediatr Nephrol 2004; 19: 526-530
4. Shibagaki Y, Shetty A. Anaemia is common after kidney transplantation, especially among African Americans. Nephrol Dial Transplant 2004; 19: 2368-2373
5. Vanrenterghem Y, Ponticelli C, Morales JM et al. Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 2003; 3: 835-845
6. Afzali B, Al-Khoury S, Shah N et al. Anemia after renal transplantation. Am J Kidney Dis 2006; 48: 519-536
7. Marsden JT. Erythropoietin-measurement and clinical applications. Ann Clin Biochem 2006; 43: 97-104
8. Nielsen OJ, Thaysen JH. Erythropoietin deficiency in acute renal failure. Lancet 1989; 1: 624-625
9. Winearls CG, Oliver DO, Pippard MJ et al. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 1986; 2: 1175-1178
10. Chatterjee PK. Pleiotropic renal actions of erythropoietin. Lancet 2005; 365: 1890-1892
11. Bahlmann FH, Song R, Boehm SM et al. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation 2004; 110: 1006-1012
12. Salahudeen AK, Haider N, Jenkins J et al. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury. Am J Physiol Renal Physiol 2008; 294: F1354-1365
13. Chua MS, Barry C, Chen X et al. Molecular profiling of anemia in acute renal allograft rejection using DNA microarrays. Am J Transplant 2003; 3: 17-22
14. Heinze G, Mitterbauer C, Regele H et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 2006; 17: 889-899
15. R Kramar RO. Austrian Dialysis and Transplantation Registry (OEDTR). Annual Report 2006. Austrian Society of Nephrology, 2007
16. Kainz A, Mitterbauer C, Hauser P et al. Alterations in gene expression in cadaveric vs. live donor kidneys suggest impaired tubular counter-balance of oxidative stress at implantation. Am J Transplant 2004; 4: 1595-1604
17. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
18. Groenewoud AF, Thorogood J. The HTK Study Group. Current status of the Eurotransplant randomized multicenter study comparing kidney graft preservation with histidine-tryptophan-ketogluterate, University of Wisconsin, and Euro-Collins solutions. Transplant Proc 1993; 25: 1582-1585
19. Perou CM, Sorlie T, Eisen MB et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747-752
20. Brazma A, Hingamp P, Quackenbush J et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001; 29: 365-371
21. Gollub J, Ball CA, Binkley G et al. The Stanford Microarray Database: data access and quality assessment tools. Nucleic Acids Res 2003; 31: 94-96
22. Troyanskaya O, Cantor M, Sherlock G et al. Missing value estimation methods for DNA microarrays. Bioinformatics 2001; 17: 520-525
23. Bolstad BM, Irizarry RA, Astrand M et al. A comparison of normalization methods for high density oligonucleotide array data based on bias and variance. Bioinformatics 2003; 19: 185-193
24. Slonim DK. From patterns to pathways: gene expression data analysis comes of age. Nat Genet 2002; 32(Suppl): 502-508
25. Saeed AI, Sharov V, White J et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003; 34: 374-378
26. Eisen MB, Spellman PT, Brown PO et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863-14868
27. MeV Team. MeV MultiExperiment Viewer. 4.0 beta ed: 2006
28. Ashburner M, Ball CA, Blake JA et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25-29
29. Diehn M, Sherlock G, Binkley G et al. SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res 2003; 31: 219-223
30. Mi H, Lazareva-Ulitsky B, Loo R et al. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 2005; 33: D284-D288
31. Hoffmann R, Valencia A. A gene network for navigating the literature. Nat Genet 2004; 36: 664
32. Brown KR, Jurisica I. Online predicted human interaction database. Bioinformatics 2005; 21: 2076-2082
33. Chen JY, Shen C, Sivachenko AY. Mining Alzheimer disease relevant proteins from integrated protein interactome data. Pac Symp Biocomput 2006; 11: 367-378
34. Blum AL, P. Selection of elevant features and examples in machine learning. Artificial Intelligence 1997; 97: 245-271
35. Coca SG, Yalavarthy R, Concato J et al. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 2008; 73: 1008-1016
36. Karakus S, Kanbay M, Koseoglu HK et al. Causes of anemia in renal transplant recipients. Transplant Proc 2004; 36: 164-165
37. Lorenz M, Winkelmayer WC, Horl WH et al. Anaemia after renal transplantation. Eur J Clin Invest 2005; 35(Suppl 3): 89-94
38. Vanrenterghem Y. Anaemia after renal transplantation. Nephrol Dial Transplant 2004; 19(Suppl 5): V54-V58
39. Halloran PF, Reeve J, Kaplan B. Lies, damn lies, and statistics: the perils of the P value. Am J Transplant 2006; 6: 10-11
40. Chhabra D, Grafals M, Skaro AI et al. Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection. Clin J Am Soc Nephrol 2008; 3: 1168-1174
41. Hauser P, Schwarz C, Mitterbauer C et al. Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function. Lab Invest 2004; 84: 353-361
42. Ghafari A, Noori-Majelan N. Anemia among long-term renal transplant recipients. Transplant Proc 2008; 40: 186-188
43. Xing C, Sivakumaran TA, Wang JJ et al. Complement factor H polymorphisms, renal phenotypes and age-related macular degeneration: the Blue Mountains Eye Study. Genes Immun 2008; 9: 231-239
44. Pemble S, Schroeder KR, Spencer SR et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 300(Pt 1): 271-276
45. Lee KA, Kim SH, Woo HY et al. Increased frequencies of glutathione S-transferase (GSTM1 and GSTT1) gene deletions in Korean patients with acquired aplastic anemia. Blood 2001; 98: 3483-3485
46. Suzuki H, Moldoveanu Z, Hall S et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest 2008; 118: 629-639
47. Lappin TR, Maxwell AP, Johnston PG. EPO's alter ego: erythropoietin has multiple actions. Stem Cells 2002; 20: 485-492